LRP2 and eye neoplasm: In ocular tumors, uniform LRP2 downregulation would therefore create a dual proliferative advantage: first, by removing SHH pathway restraint (as demonstrated by Christensen et al.), and second, by depriving cells of differentiation signals ordinarily transduced through vitamin A and D-dependent transcriptional programs [56,57,58].